XML 27 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Adjustment
Retained Earnings
Accumulated Other Comprehensive Loss
Adjustment
Total
Balance at Mar. 31, 2021 $ 223 $ 63,650   $ 87,881 $ (160)   $ 151,594
Balance (in shares) at Mar. 31, 2021 22,351,235            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       21,820     21,820
Cash dividends on common stock       (4,769)     (4,769)
Exercise of stock options   17   (1)     $ 16
Exercise of stock options (in shares) 6,000           6,000
Stock repurchased $ (2) (1,938)         $ (1,940)
Stock repurchased (in shares) (278,148)            
Restricted stock grants (in shares) 69,285            
Restricted stock cancelled (in shares) (20,976)            
Stock-based compensation, net   319         319
Other comprehensive income (loss), net         (9,791)   (9,791)
Balance at Mar. 31, 2022 $ 221 62,048   104,931 (9,951)   157,249
Balance (in shares) at Mar. 31, 2022 22,127,396            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       18,069     18,069
Cash dividends on common stock       (5,174)     (5,174)
Exercise of stock options   4         $ 4
Exercise of stock options (in shares) 1,511           1,511
Stock repurchased $ (9) (6,697)         $ (6,706)
Stock repurchased (in shares) (975,666)            
Restricted stock grants and forfeited, net (in shares) 68,719            
Stock-based compensation, net   390         390
Purchase of subsidiary shares from noncontrolling interest   (234)         (234)
Other comprehensive income (loss), net         (8,359)   (8,359)
Balance at Mar. 31, 2023 $ 212 55,511   117,826 (18,310)   155,239
Balance (in shares) at Mar. 31, 2023 21,221,960            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       3,799     3,799
Cash dividends on common stock       (5,073)     (5,073)
Exercise of stock options   36         $ 36
Exercise of stock options (in shares) 12,799           12,799
Stock repurchased $ (1) (576)         $ (577)
Stock repurchased (in shares) (109,162)            
Restricted stock grants and forfeited, net (in shares) (14,554)            
Stock-based compensation, net   34         34
Other comprehensive income (loss), net         2,183   2,183
Balance at Mar. 31, 2024 $ 211 $ 55,005 $ (53) $ 116,499 $ (16,127) $ (53) $ 155,588
Balance (in shares) at Mar. 31, 2024 21,111,043